Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$9.72M Sell
163,234
-3,976
-2% -$233K 2.95% 7
2016
Q2
$9.19M Buy
167,210
+1,295
+0.8% +$68.9K 2.82% 11
2016
Q1
$8.38M Buy
165,915
+4,239
+3% +$208K 2.72% 13
2015
Q4
$8.15M Sell
161,676
-558
-0.3% -$28.1K 2.68% 14
2015
Q3
$7.65M Buy
162,234
+13,846
+9% +$736K 2.77% 13
2015
Q2
$8.06M Buy
148,388
+130
+0.1% +$7.29K 2.98% 10
2015
Q1
$8.13M Buy
148,258
+1,535
+1% +$86.9K 2.87% 16
2014
Q4
$7.95M Buy
146,723
+1,391
+1% +$77.5K 2.73% 20
2014
Q3
$8.22M Sell
145,332
-1,372
-0.9% -$77K 2.98% 12
2014
Q2
$8.1M Sell
146,704
-697
-0.5% -$38K 2.96% 12
2014
Q1
$7.99M Buy
147,401
+2,447
+2% +$127K 2.99% 12
2013
Q4
$6.92M Buy
144,954
+1,220
+0.8% +$55.8K 2.73% 17
2013
Q3
$6.53M Buy
143,734
+2,576
+2% +$118K 2.8% 18
2013
Q2
$6.26M Buy
+141,158
New +$6.3M 2.78% 17

Other funds holding MRK

Acadia Trust's MRK Position: Q3 2016 in Review

Acadia Trust reduced its Merck (MRK) stake by 2.4% in Q3 2016, selling an estimated $233K and leaving 163,234 shares worth $9.72M. The position accounts for 2.95% of the portfolio, ranked #7.

Acadia Trust first reported a position in MRK in Q2 2013 and has held it in 14 quarters since. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

  • Acadia Trust held 163,234 shares of Merck worth $9.72M as of Q3 2016.
  • Acadia Trust sold 3,976 Merck shares in Q3 2016, an estimated $233K.
  • Merck made up 2.95% of Acadia Trust's portfolio in Q3 2016, its #7 holding.
  • Acadia Trust first reported a position in Merck in Q2 2013 and has held it in 14 quarters since.
  • 1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Acadia Trust's 13F filing for Q3 2016, filed 15 Nov 2016.